Literature DB >> 34610329

Adaptations in Hippo-Yap signaling and myofibroblast fate underlie scar-free ear appendage wound healing in spiny mice.

Chris M Brewer1, Branden R Nelson2, Paul Wakenight3, Sarah J Collins4, Daryl M Okamura5, Xiu Rong Dong4, William M Mahoney6, Aaron McKenna7, Jay Shendure8, Andrew Timms4, Kathleen J Millen9, Mark W Majesky10.   

Abstract

Spiny mice (Acomys cahirinus) are terrestrial mammals that evolved unique scar-free regenerative wound-healing properties. Myofibroblasts (MFs) are the major scar-forming cell type in skin. We found that following traumatic injury to ear pinnae, MFs appeared rapidly in both Acomys and mouse yet persisted only in mouse. The timing of MF loss in Acomys correlated with wound closure, blastema differentiation, and nuclear localization of the Hippo pathway target protein Yap. Experiments in vitro revealed an accelerated PP2A-dependent dephosphorylation activity that maintained nuclear Yap in Acomys dermal fibroblasts (DFs) and was not detected in mouse or human DFs. Treatment of Acomys in vivo with the nuclear Yap-TEAD inhibitor verteporfin prolonged MF persistence and converted tissue regeneration to fibrosis. Forced Yap activity prevented and rescued TGF-β1-induced human MF formation in vitro. These results suggest that Acomys evolved modifications of Yap activity and MF fate important for scar-free regenerative wound healing in vivo.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo-Yap; adipocytes; blastema; chrondrogenesis; fibrosis; hair follicle neogenesis; melanocytes; myofibroblast; regeneration; reprogramming

Mesh:

Substances:

Year:  2021        PMID: 34610329      PMCID: PMC8623355          DOI: 10.1016/j.devcel.2021.09.008

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   13.417


  112 in total

Review 1.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

Review 2.  The role of elastin-derived peptides in human physiology and diseases.

Authors:  Aurélie Le Page; Abdelouahed Khalil; Patrick Vermette; Eric H Frost; Anis Larbi; Jacek M Witkowski; Tamas Fulop
Journal:  Matrix Biol       Date:  2019-07-08       Impact factor: 11.583

3.  Origin and differentiative capacities of cells in the blastema of the regenerating salamander limb.

Authors:  T P Steen
Journal:  Am Zool       Date:  1970-05

4.  Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1.

Authors:  S Mitsuhashi; N Matsuura; M Ubukata; H Oikawa; H Shima; K Kikuchi
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

Review 5.  Collagen cross-linking mediated by lysyl hydroxylase 2: an enzymatic battlefield to combat fibrosis.

Authors:  Bram Piersma; Ruud A Bank
Journal:  Essays Biochem       Date:  2019-09-13       Impact factor: 8.000

Review 6.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

7.  Yap/Taz Deletion in Gli+ Cell-Derived Myofibroblasts Attenuates Fibrosis.

Authors:  Ming Liang; Michael Yu; Ruohan Xia; Ke Song; Jun Wang; Jinlong Luo; Guang Chen; Jizhong Cheng
Journal:  J Am Soc Nephrol       Date:  2017-08-02       Impact factor: 10.121

Review 8.  Fibroblasts: Origins, definitions, and functions in health and disease.

Authors:  Maksim V Plikus; Xiaojie Wang; Sarthak Sinha; Elvira Forte; Sean M Thompson; Erica L Herzog; Ryan R Driskell; Nadia Rosenthal; Jeff Biernaskie; Valerie Horsley
Journal:  Cell       Date:  2021-07-22       Impact factor: 66.850

Review 9.  Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.

Authors:  Fransiska Malfait; Richard J Wenstrup; Anne De Paepe
Journal:  Genet Med       Date:  2010-10       Impact factor: 8.822

10.  Verteporfin as a Medical Treatment in Peyronie's Disease.

Authors:  Daan C J Mohede; Igle Jan de Jong; Ruud A Bank; Mels F van Driel
Journal:  Sex Med       Date:  2018-09-28       Impact factor: 2.491

View more
  6 in total

Review 1.  Mammalian organ regeneration in spiny mice.

Authors:  Daryl M Okamura; Elizabeth D Nguyen; Sarah J Collins; Kevin Yoon; Joshua B Gere; Mary C M Weiser-Evans; David R Beier; Mark W Majesky
Journal:  J Muscle Res Cell Motil       Date:  2022-09-21       Impact factor: 3.352

2.  Parallel Single-Cell Multiomics Analysis of Neonatal Skin Reveals the Transitional Fibroblast States that Restrict Differentiation into Distinct Fates.

Authors:  Sean M Thompson; Quan M Phan; Sarayut Winuthayanon; Iwona M Driskell; Ryan R Driskell
Journal:  J Invest Dermatol       Date:  2021-12-17       Impact factor: 7.590

Review 3.  Cell-3D matrix interactions: recent advances and opportunities.

Authors:  Kenneth M Yamada; Andrew D Doyle; Jiaoyang Lu
Journal:  Trends Cell Biol       Date:  2022-04-08       Impact factor: 21.167

Review 4.  Fibroblasts in Scar Formation: Biology and Clinical Translation.

Authors:  Huan Qian; Yihan Shan; Ruicheng Gong; Danfeng Lin; Mengwen Zhang; Chen Wang; Lu Wang
Journal:  Oxid Med Cell Longev       Date:  2022-05-12       Impact factor: 7.310

5.  Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation.

Authors:  Xinxin Ren; Xiang Wang; Yuanliang Yan; Xi Chen; Yuan Cai; Qiuju Liang; Bi Peng; Zhijie Xu; Qingchun He; Fanhua Kang; Jianbo Li; Wenqin Zhang; Qianhui Hong; Jinwu Peng; Muzhang Xiao
Journal:  Aging (Albany NY)       Date:  2022-01-25       Impact factor: 5.682

Review 6.  Novel prospects for scarless wound healing: The roles of myofibroblasts and adipocytes.

Authors:  Ying-Ying Teng; Ming-Li Zou; Xiao-Jin Zhou; Jun-Jie Wu; Si-Yu Liu; Zheng-Dong Yuan; Yuan Jia; Kai-Wen Zhang; Xia Li; Jun-Xing Ye; Feng-Lai Yuan
Journal:  J Cell Mol Med       Date:  2022-09-15       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.